OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Engineered nanomedicines to overcome resistance of pancreatic cancer to immunotherapy
Ahmed O. Elzoghby, Cristina R. Ferrone, Soldano Ferrone, et al.
Drug Discovery Today (2022) Vol. 28, Iss. 1, pp. 103434-103434
Closed Access | Times Cited: 6
Ahmed O. Elzoghby, Cristina R. Ferrone, Soldano Ferrone, et al.
Drug Discovery Today (2022) Vol. 28, Iss. 1, pp. 103434-103434
Closed Access | Times Cited: 6
Showing 6 citing articles:
BioMOF-Based Anti-Cancer Drug Delivery Systems
Sandy Elmehrath, Ha L. Nguyen, Sherif M. Karam, et al.
Nanomaterials (2023) Vol. 13, Iss. 5, pp. 953-953
Open Access | Times Cited: 34
Sandy Elmehrath, Ha L. Nguyen, Sherif M. Karam, et al.
Nanomaterials (2023) Vol. 13, Iss. 5, pp. 953-953
Open Access | Times Cited: 34
Conquering chemoresistance in pancreatic cancer: Exploring novel drug therapies and delivery approaches amidst desmoplasia and hypoxia
Pavan Kumar Chintamaneni, Sai Kiran S. S. Pindiprolu, Swati Swagatika Swain, et al.
Cancer Letters (2024) Vol. 588, pp. 216782-216782
Open Access | Times Cited: 10
Pavan Kumar Chintamaneni, Sai Kiran S. S. Pindiprolu, Swati Swagatika Swain, et al.
Cancer Letters (2024) Vol. 588, pp. 216782-216782
Open Access | Times Cited: 10
New avenues for the treatment of immunotherapy-resistant pancreatic cancer
Luis Guilherme de Oliveira Silva, Fabian Fellipe Bueno Lemos, Marcel Silva Luz, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 4, pp. 1134-1153
Open Access | Times Cited: 2
Luis Guilherme de Oliveira Silva, Fabian Fellipe Bueno Lemos, Marcel Silva Luz, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 4, pp. 1134-1153
Open Access | Times Cited: 2
Reprogramming of cancer-associated fibroblasts combined with immune checkpoint inhibitors: A potential therapeutic strategy for cancers
Min Li, Baokang Wu, Lunxu Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 5, pp. 188945-188945
Closed Access | Times Cited: 6
Min Li, Baokang Wu, Lunxu Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 5, pp. 188945-188945
Closed Access | Times Cited: 6
Application of artificial intelligence and machine learning in pancreatic cancer immunotherapy
Nadia Ahmed, Rebecca P. Gorrie, Teymour Meguid, et al.
Elsevier eBooks (2024), pp. 143-158
Closed Access
Nadia Ahmed, Rebecca P. Gorrie, Teymour Meguid, et al.
Elsevier eBooks (2024), pp. 143-158
Closed Access
Emerging Nanotechnology in Preclinical Pancreatic Cancer Immunotherapy: Driving Towards Clinical Applications
Xuan Pan, ting han, Zixuan Zhao, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 6619-6641
Open Access
Xuan Pan, ting han, Zixuan Zhao, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 6619-6641
Open Access
